{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T07:10:53Z","timestamp":1697958653448},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":6895,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1989,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Endogenous opioids inhibit the release of oxytocin (OT) when vasopressin (AVP) is secreted in response to acute pharmacological stimuli in man and to a variety of physiological and pharmacological stimuli to animals. We have investigated the effect of naloxone on the AVP and OT responses to hypertonic saline in man. In two separate studies, six male subjects were infused with hypertonic saline (675 mmol\/l, 0.05 ml\/kg\/min for 2 h) and either naloxone (4 mg bolus and 6 mg\/h) or normal saline in random order. Hypertonic saline resulted in similar significant rises of plasma osmolality and AVP in both groups and a small but significant decrease in OT. Thirst sensation was not altered by naloxone. Endogenous opioids do not play an important role in the suppression of OT release when AVP is secreted in response to an osmotic stimulus in man.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1989.tb01422.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T11:22:17Z","timestamp":1205752937000},"page":"513-518","source":"Crossref","is-referenced-by-count":2,"title":["VASOPRESSIN AND OXYTOCIN RESPONSES TO HYPERTONIC SALINE INFUSION: EFFECT OF THE OPIOID ANTAGONIST NALOXONE"],"prefix":"10.1111","volume":"30","author":[{"given":"J. R.","family":"SECKL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"JOHNSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"LIGHTMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/298161a0"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000124168"},{"key":"e_1_2_1_4_1","first-page":"9P","article-title":"Opioid receptor subtypes mediating inhibition of oxytocin, vasopressin and noradrenaline release from the rat neurohypophysis in vitro","volume":"388","author":"Bicknell R.J.","year":"1987","journal-title":"Journal of Physiology"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-1-27"},{"key":"e_1_2_1_6_1","first-page":"95","article-title":"Inhibition of vasopressin secretion by a k\u2010opiate receptor agonist","volume":"6","author":"Carter D. A.","year":"1984","journal-title":"Neuroendorinology Letters"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(87)90128-5"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1110239"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/282746a0"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000124475"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-119-1-1"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-121-2-536"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)91346-6"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000123257"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/284350a0"},{"key":"e_1_2_1_16_1","first-page":"463","article-title":"Diuresis and suppression of vasopressin by kappa opioids: Comparison with mu and delta opioids and clonidine","volume":"234","author":"Leander J.D.","year":"1985","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1523\/JNEUROSCI.02-01-00078.1982","article-title":"Dopamine and [d\u2010Ala, d\u2010Leu] enkaphalin inhibit the electrically stimulated neurohypophyseal release of vasopressin in vitro: Evidence for calcium\u2010dependent opiate action","volume":"2","author":"Lightman S.L.","year":"1982","journal-title":"The Journal of Neuroscience"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1987.sp016858"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/289502a0"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00512071"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-4-738"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-121-1-48"},{"key":"e_1_2_1_23_1","first-page":"333","article-title":"The regulation of vasopressin function in health and disease","volume":"33","author":"Robertson G.L.","year":"1977","journal-title":"Recent Progress in Hormone Research"},{"key":"e_1_2_1_24_1","first-page":"154","volume-title":"Neuroendocrinology","author":"Robinson I.C.A.F.","year":"1986"},{"key":"e_1_2_1_25_1","first-page":"77","article-title":"Opioid\u2010mediated inhibition of oxytocin during insulin\u2010induced hypoglycaemic stimulation of vasopressin in man","volume":"118","author":"Seckl J.R.","year":"1988","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1988.tb03685.x"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1150317"},{"key":"e_1_2_1_28_1","first-page":"R214","article-title":"Oral hypertonic saline causes transient fall of vasopressin in humans","volume":"251","author":"Seckl J.R.","year":"1986","journal-title":"American Journal of Physiology"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1070097"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-121-1-384"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(84)90605-X"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6121376"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6648526"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1989.tb01422.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1989.tb01422.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T01:01:42Z","timestamp":1697936502000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1989.tb01422.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1989,5]]}},"alternative-id":["10.1111\/j.1365-2265.1989.tb01422.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1989.tb01422.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,5]]}}}